Robert von Rosen
Attorney at Law
Partner

Robert von Rosen Robert von Rosen Robert von Rosen Robert von Rosen


Robert von Rosen is a partner in the Basel office of Walder Wyss. His practice focuses on domestic and international M&A transactions (mainly private M&A/private equity and venture capital) with a focus on telecommunication, energy and life sciences. In addition, he advises mainly medium-sized and start-up companies on questions of corporate governance, compliance, restructuring and all other legal aspects of day-to-day business operations.

After completing an apprenticeship in banking, Robert von Rosen studied at the Albert-Ludwigs-University Freiburg, Germany (law exam 2004, bar exam 2006). During that time, he worked as scientific assistant at the professorship in civil law, industrial property protection and copyright law. Before joining Walder Wyss, Robert von Rosen worked for eight years at a leading Swiss law firm, supplemented by a secondment with the Swiss Financial Market Supervisory Authority FINMA.

Robert von Rosen practices in German and English. He is registered with the Basel bar registry and is also admitted to the bar in Germany.

Contact
Robert von Rosen
Direct phone: + 41 58 658 14 63


Walder Wyss Ltd.
Aeschenvorstadt 48
P.O. Box 633
4010 Basel
Switzerland
Phone +41 58 658 10 00
Fax +41 58 658 59 59
vCard


Practice Areas

Robert von Rosen Robert von Rosen Robert von Rosen Robert von Rosen

Robert von Rosen
Attorney at Law
Partner

Robert von Rosen is a partner in the Basel office of Walder Wyss. His practice focuses on domestic and international M&A transactions (mainly private M&A/private equity and venture capital) with a focus on telecommunication, energy and life sciences. In addition, he advises mainly medium-sized and start-up companies on questions of corporate governance, compliance, restructuring and all other legal aspects of day-to-day business operations.

After completing an apprenticeship in banking, Robert von Rosen studied at the Albert-Ludwigs-University Freiburg, Germany (law exam 2004, bar exam 2006). During that time, he worked as scientific assistant at the professorship in civil law, industrial property protection and copyright law. Before joining Walder Wyss, Robert von Rosen worked for eight years at a leading Swiss law firm, supplemented by a secondment with the Swiss Financial Market Supervisory Authority FINMA.

Robert von Rosen practices in German and English. He is registered with the Basel bar registry and is also admitted to the bar in Germany.

Robert von Rosen
Direct phone: + 41 58 658 14 63

Walder Wyss Ltd.
Aeschenvorstadt 48
P.O. Box 633
4010 Basel
Switzerland
Phone +41 58 658 10 00
Fax +41 58 658 59 59


vCard

Practice Areas

No publication found with your search criteria.


Deals and Cases

Precision Surfacing Solutions acquires Meyer Burger's wafering business

Precision Surfacing Solutions (PSS) (formerly Lapmaster Wolters Ltd), a global supplier of equipment and services for surface enhancement technology, intends to acquire from Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) the wafering business consisting of photovoltaic and specialised materials (e.g. semiconductor and sapphire glass industries) wafering equipment and service business. As part of the transaction, significant parts of Meyer Burger's current production facilities in Thun as well as around 100 employees involved in the wafering technology portfolio in Thun and the relevant service locations worldwide will also be transferred to PSS. Completion of the contract is subject to standard closing conditions. The closing of the transaction is expected to be completed towards the end of the first quarter of 2019. The agreed purchase price is CHF 50 million plus earn-out component. Both Meyer Burger and PSS view the transaction as an important strategic milestone, which will further strengthen two global technology leaders. 

PSS is a recognized industry leader in the development of technology to produce micron accuracy surface finishes. PSS is headquartered in Mt. Prospect, IL/USA, employing over 900 people across 13 manufacturing facilities on three continents. 

Walder Wyss has advised PSS on this transaction. The Walder Wyss team was led by Robert von Rosen (Partner, Corporate/M&A) and included Alexander Gutmans (Partner, Corporate/M&A), Thomas P. Müller (Partner, Real Estate), Markus R. Frick (Partner, IP/IT), Fabian Looser (Managing Associate, Employment), Vanessa C. Haubensak (Associate, Corporate), Christoph Zogg (Associate, Litigation) und Flora Stanischewski (Associate, Commercial).


SHS invests in Swiss life science company evitria AG

The SHS V fund managed by Tübingen-based SHS Gesellschaft für Beteiligungsmanagement has acquired a joint stake in Swiss evitria AG together with AFINUM. The life science company supplies large pharmaceutical and biotech companies with customized antibodies for research purposes. 

SHS Gesellschaft für Beteiligungsmanagement is based in Tübingen, Germany and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. It was founded in 1993 and has since then gained extensive experience as an industry investor, which supports the growth of its portfolio companies through a network of partnerships, regulatory issues or entering new markets. 

Walder Wyss has advised SHS as legal advisor in this transaction. The team included Robert von Rosen (Partner, Corporate/M&A), Alexander Gutmans (Partner, Corporate/Venture Capital), Martin Busenhart (Partner, Tax) and Luciano Schmid (Associate, Tax).


Cellestia Biotech AG: CHF 20 million Series A financing round

Walder Wyss advises FC Capital Fund I, L.P., Shanghai, as investor in connection with Cellestia's recent financing round. Cellestia was founded in 2014 as a spin-off from EPFL (Ecole Polytechnique Fédérale de Lausanne). Its pipeline including lead candidate, oral small molecule CB-103 is based on proprietary know-how and more than two decades of research at Swiss Institute for Experimental Cancer Research (ISREC) at EPFL.

The Walder Wyss team included Alexander Gutmans (Partner, Corporate, Venture Capital), Stefano Codoni (Partner, IP Life Sciences), Robert von Rosen (Partner, Corporate M&A), Jessica Aeschbach Flórez (Associate, Corporate) as well as Vanessa C. Haubensak (Associate, Corporate).


BC Platforms CHF 10 Mio. B Round

Walder Wyss advises BC Platforms AG, Basel, on its Series B financing Round. The financing round amounts to CHF 10 mio. was subscribed by Debiopharm Innovation Fund and Finnish Industry Investment as lead investors as well as by existing shareholders.

The Walder Wyss teams consisted of Alexander Gutmans (Partner, Corporate Venture Capital, Life Sciences), Robert von Rosen (Partner, Corporate) and Vanessa C. Haubensak (Associate, Corporate).


RWS acquires LUZ, Inc.

RWS Holdings plc, a world leading provider of intellectual property support services (patent translations, international patent filing solutions and searches), commercial translations and linguistic validation, has completed the acquisition of 100% of LUZ, Inc., a market leading Life Sciences language services provider based in San Francisco, for a cash consideration of USD82.5m.

Based in San Francisco, LUZ is a market leading life sciences translation provider, specializing in medical devices and regulatory activities. LUZ services a number of the world’s leading pharmaceutical and medical device manufacturers, enjoying a preferred supplier relationship with certain customers. The acquisition strengthens RWS’s leading position in global Life Sciences both in the US and Europe.

Walder Wyss acted as RWS' legal advisor on that transaction. The team was led by Robert von Rosen (Partner, Corporate M&A) and further included Alexander Gutmans (Partner, Corporate M&A), Michael Isler (Partner, IP/IT), David M. Hill (Associate, Employment) and Jonas Knechtli (Associate, Corporate/Commercial).


Curriculum Vitae PDF